APO Research
Talk to an analyst

APO RESEARCH · REPORT

Progestin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Progestin Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchProgestin Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Progestin Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Progestin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Progestin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Progestin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Progestin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Progestin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Progestin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Progestin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Progestin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Progestin market include Zhejiang Medicine, Zhejiang Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical, Teva Generics, Merck, Virtus Pharmaceuticals, LLC, BionPharma and Besins Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Progestin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Progestin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Progestin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Progestin market size, projected growth trends, production technologies, key applications, and end-use industries.

Progestin Segment by Company

Zhejiang Medicine

Zhejiang Xianju Pharmaceutical

Zhejiang Aisheng Pharmaceutical

Teva Generics

Merck

Virtus Pharmaceuticals, LLC

BionPharma

Besins Healthcare

Progestin Segment by Type

Progestin Oral

Progestin Injection

Progestin Suspended/Gel

Progestin Segment by Application

Pharmacies & Drug Stores

Hospital

Clinic

Progestin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Progestin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Progestin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Progestin significant trends, drivers, influence factors in global and regions.

6. To analyze Progestin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Progestin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Progestin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Progestin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Progestin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Progestin industry.

Chapter 3: Detailed analysis of Progestin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Progestin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Progestin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Progestin Industry Trends Table 2. Progestin Industry Drivers Table 3. Progestin Industry Opportunities and Challenges Table 4. Progestin Industry Restraints Table 5. Global Progestin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Progestin Revenue Share by Company (2021-2026) Table 7. Global Progestin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Progestin Sales Volume Share by Company (2021-2026) Table 9. Global Progestin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Progestin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Progestin Key Company Manufacturing Base & Headquarters Table 12. Global Progestin Company, Product Type & Application Table 13. Global Progestin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Progestin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Progestin Oral Table 18. Significant Companies of Progestin Injection Table 19. Significant Companies of Progestin Suspended/Gel Table 20. Global Progestin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Progestin Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Progestin Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Progestin Sales Volume Share by Type (2021-2026) Table 24. Global Progestin Sales Volume Share by Type (2027-2032) Table 25. Global Progestin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Progestin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Progestin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Progestin Sales Value Share by Type (2021-2026) Table 29. Global Progestin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmacies & Drug Stores Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Global Progestin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Progestin Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Progestin Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Progestin Sales Volume Share by Application (2021-2026) Table 37. Global Progestin Sales Volume Share by Application (2027-2032) Table 38. Global Progestin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Progestin Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Progestin Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Progestin Sales Value Share by Application (2021-2026) Table 42. Global Progestin Sales Value Share by Application (2027-2032) Table 43. Global Progestin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Progestin Sales by Region (2021-2026) & (K Units) Table 45. Global Progestin Sales Market Share by Region (2021-2026) Table 46. Global Progestin Sales by Region (2027-2032) & (K Units) Table 47. Global Progestin Sales Market Share by Region (2027-2032) Table 48. Global Progestin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Progestin Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Progestin Sales Value Share by Region (2021-2026) Table 51. Global Progestin Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Progestin Sales Value Share by Region (2027-2032) Table 53. Global Progestin Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Progestin Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Progestin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Progestin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Progestin Sales by Country (2021-2026) & (K Units) Table 58. Global Progestin Sales Market Share by Country (2021-2026) Table 59. Global Progestin Sales by Country (2027-2032) & (K Units) Table 60. Global Progestin Sales Market Share by Country (2027-2032) Table 61. Global Progestin Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Progestin Sales Value Market Share by Country (2021-2026) Table 63. Global Progestin Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Progestin Sales Value Market Share by Country (2027-2032) Table 65. Zhejiang Medicine Company Information Table 66. Zhejiang Medicine Business Overview Table 67. Zhejiang Medicine Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhejiang Medicine Progestin Product Portfolio Table 69. Zhejiang Medicine Recent Development Table 70. Zhejiang Xianju Pharmaceutical Company Information Table 71. Zhejiang Xianju Pharmaceutical Business Overview Table 72. Zhejiang Xianju Pharmaceutical Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Zhejiang Xianju Pharmaceutical Progestin Product Portfolio Table 74. Zhejiang Xianju Pharmaceutical Recent Development Table 75. Zhejiang Aisheng Pharmaceutical Company Information Table 76. Zhejiang Aisheng Pharmaceutical Business Overview Table 77. Zhejiang Aisheng Pharmaceutical Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Zhejiang Aisheng Pharmaceutical Progestin Product Portfolio Table 79. Zhejiang Aisheng Pharmaceutical Recent Development Table 80. Teva Generics Company Information Table 81. Teva Generics Business Overview Table 82. Teva Generics Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Teva Generics Progestin Product Portfolio Table 84. Teva Generics Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Merck Progestin Product Portfolio Table 89. Merck Recent Development Table 90. Virtus Pharmaceuticals, LLC Company Information Table 91. Virtus Pharmaceuticals, LLC Business Overview Table 92. Virtus Pharmaceuticals, LLC Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Virtus Pharmaceuticals, LLC Progestin Product Portfolio Table 94. Virtus Pharmaceuticals, LLC Recent Development Table 95. BionPharma Company Information Table 96. BionPharma Business Overview Table 97. BionPharma Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. BionPharma Progestin Product Portfolio Table 99. BionPharma Recent Development Table 100. Besins Healthcare Company Information Table 101. Besins Healthcare Business Overview Table 102. Besins Healthcare Progestin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Besins Healthcare Progestin Product Portfolio Table 104. Besins Healthcare Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Progestin Distributors List Table 108. Progestin Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Progestin Product Image Figure 2. Global Progestin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Progestin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Progestin Sales (2021-2032) & (K Units) Figure 5. Global Progestin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Progestin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Progestin Oral Image Figure 10. Progestin Injection Image Figure 11. Progestin Suspended/Gel Image Figure 12. Global Progestin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Progestin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Progestin Sales Volume Share by Type (2021-2032) Figure 15. Global Progestin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Progestin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Progestin Sales Value Share by Type (2021-2032) Figure 18. Pharmacies & Drug Stores Image Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Global Progestin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Progestin Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Progestin Sales Volume Share by Application (2021-2032) Figure 24. Global Progestin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Progestin Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Progestin Sales Value Share by Application (2021-2032) Figure 27. Global Progestin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Progestin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Progestin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Progestin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Progestin Sales Value (2021-2032) & (US$ Million) Figure 32. North America Progestin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Progestin Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Progestin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Progestin Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Progestin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Progestin Sales Value (2021-2032) & (US$ Million) Figure 38. South America Progestin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Progestin Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Progestin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Progestin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Progestin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Progestin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Progestin Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Progestin Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Progestin Oral
  • Progestin Injection
  • Progestin Suspended/Gel
Applications
  • Pharmacies & Drug Stores
  • Hospital
  • Clinic
Companies covered
  • Zhejiang Medicine
  • Zhejiang Xianju Pharmaceutical
  • Zhejiang Aisheng Pharmaceutical
  • Teva Generics
  • Merck
  • Virtus Pharmaceuticals, LLC
  • BionPharma
  • Besins Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Progestin Sales Value (2021-2032)
  4. 1.2.2 Global Progestin Sales Volume (2021-2032)
  5. 1.2.3 Global Progestin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Progestin Market Dynamics
  1. 2.1 Progestin Industry Trends
  2. 2.2 Progestin Industry Drivers
  3. 2.3 Progestin Industry Opportunities and Challenges
  4. 2.4 Progestin Industry Restraints
3 Progestin Market by Company
  1. 3.1 Global Progestin Company Revenue Ranking in 2025
  2. 3.2 Global Progestin Revenue by Company (2021-2026)
  3. 3.3 Global Progestin Sales Volume by Company (2021-2026)
  4. 3.4 Global Progestin Average Price by Company (2021-2026)
  5. 3.5 Global Progestin Company Ranking (2024-2026)
  6. 3.6 Global Progestin Company Manufacturing Base and Headquarters
  7. 3.7 Global Progestin Company Product Type and Application
  8. 3.8 Global Progestin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Progestin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Progestin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Progestin Market by Type
  1. 4.1 Progestin Type Introduction
  2. 4.1.1 Progestin Oral
  3. 4.1.2 Progestin Injection
  4. 4.1.3 Progestin Suspended/Gel
  5. 4.2 Global Progestin Sales Volume by Type
  6. 4.2.1 Global Progestin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Progestin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Progestin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Progestin Sales Value by Type
  10. 4.3.1 Global Progestin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Progestin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Progestin Sales Value Share by Type (2021-2032)
5 Progestin Market by Application
  1. 5.1 Progestin Application Introduction
  2. 5.1.1 Pharmacies & Drug Stores
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Progestin Sales Volume by Application
  6. 5.2.1 Global Progestin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Progestin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Progestin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Progestin Sales Value by Application
  10. 5.3.1 Global Progestin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Progestin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Progestin Sales Value Share by Application (2021-2032)
6 Progestin Regional Sales and Value Analysis
  1. 6.1 Global Progestin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Progestin Sales by Region (2021-2032)
  3. 6.2.1 Global Progestin Sales by Region: 2021-2026
  4. 6.2.2 Global Progestin Sales by Region (2027-2032)
  5. 6.3 Global Progestin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Progestin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Progestin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Progestin Sales Value by Region (2027-2032)
  9. 6.5 Global Progestin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Progestin Sales Value (2021-2032)
  12. 6.6.2 North America Progestin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Progestin Sales Value (2021-2032)
  15. 6.7.2 Europe Progestin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Progestin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Progestin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Progestin Sales Value (2021-2032)
  21. 6.9.2 South America Progestin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Progestin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Progestin Sales Value Share by Country, 2025 VS 2032
7 Progestin Country-level Sales and Value Analysis
  1. 7.1 Global Progestin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Progestin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Progestin Sales by Country (2021-2032)
  4. 7.3.1 Global Progestin Sales by Country (2021-2026)
  5. 7.3.2 Global Progestin Sales by Country (2027-2032)
  6. 7.4 Global Progestin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Progestin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Progestin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Progestin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Progestin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Progestin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Progestin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Progestin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Progestin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Progestin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Progestin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Progestin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Progestin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Progestin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Progestin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Progestin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Progestin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Progestin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Progestin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Progestin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Progestin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Progestin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Progestin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Progestin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Progestin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Progestin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Progestin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Progestin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Progestin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Progestin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Progestin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Progestin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Progestin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Progestin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Progestin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Progestin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Progestin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Progestin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Progestin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Progestin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Progestin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Progestin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Progestin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Progestin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Progestin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Progestin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Progestin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Progestin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Progestin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Progestin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Progestin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Progestin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Progestin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Progestin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Progestin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Progestin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Progestin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Progestin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Progestin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Progestin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Progestin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Progestin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Progestin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Progestin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Progestin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Progestin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Progestin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Progestin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Progestin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Progestin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Progestin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Progestin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Progestin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Progestin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Progestin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Progestin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Progestin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Progestin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Progestin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Progestin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Progestin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Progestin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Progestin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Progestin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Progestin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Progestin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Progestin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Medicine
  2. 8.1.1 Zhejiang Medicine Company Information
  3. 8.1.2 Zhejiang Medicine Business Overview
  4. 8.1.3 Zhejiang Medicine Progestin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Medicine Progestin Product Portfolio
  6. 8.1.5 Zhejiang Medicine Recent Developments
  7. 8.2 Zhejiang Xianju Pharmaceutical
  8. 8.2.1 Zhejiang Xianju Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Xianju Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Xianju Pharmaceutical Progestin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Xianju Pharmaceutical Progestin Product Portfolio
  12. 8.2.5 Zhejiang Xianju Pharmaceutical Recent Developments
  13. 8.3 Zhejiang Aisheng Pharmaceutical
  14. 8.3.1 Zhejiang Aisheng Pharmaceutical Company Information
  15. 8.3.2 Zhejiang Aisheng Pharmaceutical Business Overview
  16. 8.3.3 Zhejiang Aisheng Pharmaceutical Progestin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang Aisheng Pharmaceutical Progestin Product Portfolio
  18. 8.3.5 Zhejiang Aisheng Pharmaceutical Recent Developments
  19. 8.4 Teva Generics
  20. 8.4.1 Teva Generics Company Information
  21. 8.4.2 Teva Generics Business Overview
  22. 8.4.3 Teva Generics Progestin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Teva Generics Progestin Product Portfolio
  24. 8.4.5 Teva Generics Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Progestin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Progestin Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Virtus Pharmaceuticals, LLC
  32. 8.6.1 Virtus Pharmaceuticals, LLC Company Information
  33. 8.6.2 Virtus Pharmaceuticals, LLC Business Overview
  34. 8.6.3 Virtus Pharmaceuticals, LLC Progestin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Virtus Pharmaceuticals, LLC Progestin Product Portfolio
  36. 8.6.5 Virtus Pharmaceuticals, LLC Recent Developments
  37. 8.7 BionPharma
  38. 8.7.1 BionPharma Company Information
  39. 8.7.2 BionPharma Business Overview
  40. 8.7.3 BionPharma Progestin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BionPharma Progestin Product Portfolio
  42. 8.7.5 BionPharma Recent Developments
  43. 8.8 Besins Healthcare
  44. 8.8.1 Besins Healthcare Company Information
  45. 8.8.2 Besins Healthcare Business Overview
  46. 8.8.3 Besins Healthcare Progestin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Besins Healthcare Progestin Product Portfolio
  48. 8.8.5 Besins Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Progestin Value Chain Analysis
  2. 9.1.1 Progestin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Progestin Sales Mode & Process
  6. 9.2 Progestin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Progestin Distributors
  9. 9.2.3 Progestin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst